Sanofi Wins Aventis With $8 Bil. In Cash And Nominal Joint Control
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi's winning bid for Aventis includes an added $8 bil. in cash, nominal joint control of the merged company, and an acknowledgment of Aventis' Franco-German heritage